January 10, 2025
September 10, 2024
August 8, 2024
January 19, 2023
Anlon Healthcare Limited IPO | Important Dates, Price, and More
Author
Shoonya Team
Anlon Healthcare Limited IPO is all set to launch its ₹121.03 crore IPO, which opens for subscription on August 26, 2025, and closes on August 29, 2025. The company will list on both BSE and NSE, with a tentative listing date of September 3, 2025.
The price band has been fixed at ₹86 – ₹91 per share, with a minimum application size of 164 shares. For retail investors, that translates into a minimum investment of about ₹14,104, while sNII and bNII investors need to apply for at least 2,296 shares and 11,152 shares, respectively.
This IPO is a complete fresh issue, aggregating to ₹121.03 crore, aimed at funding business expansion, strengthening the balance sheet, and supporting working capital requirements.
Here are the Quick Steps to Apply for the Anlon Healthcare Limited IPO!
Anlon Healthcare Limited IPO | IPO Details
| Detail | Information |
| IPO Opening Date | August 26, 2025 |
| IPO Closing Date | August 29, 2025 |
| Tentative IPO Listing Date | September 3, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹86 – ₹91 per share |
| Lot Size | 164 shares |
| Total Issue Size | 1,33,00,000 shares (₹121.03 Cr) |
| Fresh Issue | 1,33,00,000 shares (₹121.03 Cr) |
| Offer for Sale (OFS) | — (No OFS, entire issue is fresh) |
| IPO Segment | Main Board – Book Building |
| Listing At | BSE, NSE |
| Shareholding Pre-Issue | 70.26% |
Anlon Healthcare Limited IPO | Company Overview
Anlon Healthcare Limited is a pharmaceutical company engaged in the manufacturing of pharma intermediates and active pharmaceutical ingredients (APIs). The company was incorporated in 2013. Its products are used in medicines, nutraceuticals, personal care, and veterinary healthcare, following both Indian and international pharmacopoeia standards such as IP, BP, EP, JP, and USP.
The company has built a strong product pipeline with 65 commercialised products, 28 products in the pilot stage, and 49 products under laboratory testing. It also provides custom manufacturing services, catering to clients who require complex, high-purity chemicals.
Anlon Healthcare has secured multiple Drug Master File (DMF) approvals from international regulatory bodies, including ANVISA (Brazil), NMPA (China), and PMDA (Japan). It has already filed 21 DMFs globally, covering products such as loxoprofen sodium dihydrate and loxoprofen acid APIs, and is in the process of filing approvals for Ketoprofen and Dexketoprofen Trometamol.The company ensures strict quality control through four dedicated labs and a team of 34 professionals, including 24 science graduates.
Anlon Healthcare Limited IPO | Key Details
- IPO Opening Date: August 26, 2025
- IPO Closing Date: August 29, 2025
- Allotment Date: September 1, 2025
- Price Band: ₹86 – ₹91 per share
- IPO Size: ₹121.03 Crores
- Refunds Initiated: September 2, 2025
- Shares Credited to Demat: September 2, 2025
- Listing Date: September 3, 2025
- Cut-off Time for UPI Mandate Confirmation: 5 PM on August 29, 2025
Anlon Healthcare Limited IPO | Financial Overview
The company has delivered strong growth in recent years, with revenue increasing by 81% and profit after tax rising by 112% in FY25 compared to FY24. This reflects the company’s expanding product portfolio and growing market reach.
Amount in ₹ Crore
| Financial Information (₹ in Crore) | 31-Mar-25 | 31-Mar-24 | Change (FY25 vs FY24) | Change % |
| Assets | 181.30 | 128.00 | +53.30 | +41.6% |
| Total Income | 120.46 | 66.69 | +53.77 | +80.6% |
| Profit After Tax | 20.52 | 9.66 | +10.86 | +112.4% |
| EBITDA | 32.38 | 15.57 | +16.81 | +108.0% |
| Net Worth | 80.42 | 21.03 | +59.39 | +282.6% |
| Reserves & Surplus | 40.57 | 5.03 | +35.54 | +706.5% |
| Total Borrowing | 58.35 | 74.56 | -16.21 | -21.7% |
Anlon Healthcare Limited IPO | FAQs
The Anlon Healthcare Limited IPO opens on August 26, 2025 and closes on August 29, 2025. The allotment is expected on September 1, 2025, and the shares will list on September 3, 2025.
The price band of Anlon Healthcare Limited IPO is fixed at ₹86 – ₹91 per share. The minimum lot size is 164 shares, requiring an investment of about ₹14,104 for retail investors.
You can apply through your broker’s trading app, bank ASBA facility, or UPI mandate. Select Anlon Healthcare Limited IPO, enter the lot size and bid price, and confirm via UPI before 5 PM on August 29, 2025.
The face value of Anlon Healthcare Limited IPO is ₹10 per share.
Refunds for non-allottees for Anlon Healthcare Limited IPO will be initiated on September 2, 2025. The shares for successful applicants will also be credited to Demat accounts on the same day.
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.
Explore Our Offerings
Stocks
Trade equities across NSE and BSE with zero delivery charges. Invest, hold or sell with a seamless experience.
Future & Options
Execute complex strategies with simple tools and real-time data.
IPOs
Apply to the latest IPOs in just a few taps. Stay updated and capture opportunities as they open.